TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CVKD

Cadrenal Therapeutics, Inc.

Healthcare · Biotechnology

1.10$ -4.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Cadrenal Therapeutics, Inc. (CVKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CVKD
Line item 2022 2023 2024 2025
-1.3 -3.5 -7.4 -13
0.1 0.0 0.0 0.0
1.0 0.7 1.4 1.9
5.3
0.2 0.1 1.9 -1.3
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 -0.3
1.3 -0.3 0.0
1.4 12 9.0 6.6
0.0 8.4 1.6 -6.0
-1.3 -3.5 -7.4 -13

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?